Hegseth's Hypocrisy on Testosterone Replacement Therapy A federal judge has raised questions about the disparity between Defense Secretary Pete Hegseth's new initiative to treat troops for low testosterone and hormone treatment for transgender men in the military.
U. S.
District Judge Ana Reyes posed the query during an ongoing lawsuit against President Donald Trump's ban on transgender troops, highlighting a broader issue: why some medical treatments are being touted as essential for cisgender service members while others are demonized or ignored.